Digital work instructions for medical device manufacturing replace paper SOPs with guided operator workflows that capture execution data, enforce revision control, and compile electronic device history records. The core decision is not whether to digitize, but how the chosen platform will interact with your quality system, software documentation level, and human factors validation evidence. Tulip describes its platform as a no-code, GxP-ready alternative to a rigid MES, while Sequence emphasizes FDA 21 CFR Part 11 signatures and controlled instruction deployment [1][2]. Neither vendor document establishes that its software is validated for a specific device or process. This guide explains the named workflow, the technical decision points, the evidence limitations in the public documents, and a concrete evaluation example for a hypothetical assembly line.
The Digital Work Instruction Workflow
A digital work instruction workflow begins when an operator opens an approved procedure on a tablet, HMI, or workstation. The software guides assembly, packaging, or inspection steps and can require confirmation before the operator proceeds. Tulip describes workflows that capture device history record data automatically during execution and states that this can eliminate delays from missing signatures, incomplete records, or manual reviews [1]. Sequence lists mandatory in-process quality checks and measurement capture among its medical device manufacturing capabilities [2]. In both descriptions, the instruction is not a static document but a sequence of enforced steps.
The workflow also includes revision control and approval. Sequence lists work instruction revision control and electronic approval workflows as a key capability, so the shop floor version matches the version reviewed by quality engineering [2]. Tulip lists a validated app lifecycle and complete audit trail support as part of its GxP-ready platform [1]. These vendor claims describe intended functionality, not evidence that a particular implementation passed an FDA inspection or validation audit. A manufacturer must still verify that the configured workflow meets its own quality system requirements.
Regulatory Documentation Boundaries
FDA guidance on device software functions does not name Tulip, Sequence, or any digital work instruction product. The guidance describes recommended documentation for premarket submissions when software functions meet the device definition under section 201(h) of the Federal Food, Drug, and Cosmetic Act [3]. The same guidance states that it does not apply to automated manufacturing and Quality System software or software that is not a device [5]. A digital work instruction platform used only for manufacturing execution may not be a device software function, but the manufacturer must make that determination based on the intended use and regulatory pathway. The guidance states that it does not apply to automated manufacturing and Quality System software or software that is not a device [5]. The guidance is nonbinding and permits alternative approaches if they satisfy applicable statutes and regulations [3].
The off-the-shelf software guidance adds a separate documentation layer when a manufacturer cannot claim complete software life cycle control [6]. The guidance defines OTS software as a generally available software component used by a medical device manufacturer for which the manufacturer cannot claim complete software life cycle control [6]. If a digital work instruction platform is treated as OTS software, the sponsor should specify the title and manufacturer of the OTS software, the version level, release date, patch number, and upgrade designation as appropriate, any OTS software documentation that will be provided to the end user, why the OTS software is appropriate for the medical device, and the expected design limitations of the OTS software [6]. The sources do not state whether Tulip or Sequence would be classified as OTS software in any specific submission. That classification depends on the manufacturer's control over the software life cycle and the role of the software in the device.
Suggested Evaluation Script for a Torque Verification Step
A practical evaluation could use a single assembly step: torque a fastener to a specified value and record the result. Configure the step in each platform so the operator must scan the work order, the software must receive a reading from a connected torque tool, and the operator must sign electronically before the next step appears. Then test three failure cases: a torque reading outside the limit, a missing signature, and an attempt to open an outdated revision. Document whether each platform blocks the step, records the failure, and produces an audit trail entry. This script tests the vendor claims about mandatory checks, revision control, and Part 11 signatures [1][2], but it does not establish regulatory compliance by itself.
Human Factors and Instruction Limits
FDA human factors guidance addresses instructions for use as one element of device labeling. The guidance states that if human factors validation testing shows use errors on critical tasks or participant feedback indicating difficulty with critical tasks, a manufacturer cannot simply claim that modifying the instructions for use or another labeling element mitigated the risk unless additional test data demonstrate the modified elements were effective in reducing the risks to acceptable levels [4]. This principle applies to labeling that accompanies a device, not necessarily to internal manufacturing work instructions. The distinction matters because a digital work instruction used by an assembler is not automatically the same as instructions for use provided to a clinician or patient.
The guidance also notes that infrequent but hazardous use scenarios can be difficult to identify, which underscores the necessity for careful application of the preliminary analyses and evaluations [4]. For manufacturing work instructions, a similar logic applies to rare assembly errors that could cause serious harm. A digital workflow can add prompts or mandatory checks, but the vendor sources do not provide human factors validation data for their platforms. Tulip describes guiding operators with digital workflows that standardize processes and catch issues before they reach quality review [1]. Sequence states that paper instructions and generic PDFs fail to prevent the 'tribal knowledge' shortcuts that lead to non-conformances during audits [2]. These are vendor claims about error reduction, not validated safety outcomes.
Tulip and Sequence: Decision Points
Tulip emphasizes a no-code app editor, edge connectivity to tools and scales, ERP integration, and AI features that convert static SOPs into workflows with logic and checks [1]. The vendor states that operators can be guided without relying on paper or complex MES systems [1]. The vendor also describes using AI to transform static SOPs into workflows with logic and checks [1]. Sequence emphasizes visual work instructions, part and batch traceability, automated eDHR compilation, and direct connectivity with PLM, ERP, and QMS systems [2]. The two products overlap on revision control, electronic signatures, and traceability, but their stated integration targets differ: Tulip names ERP, QMS, and inventory systems, while Sequence names PLM, ERP, and QMS [1][2]. Tulip also lists edge connectivity for connected tools, sensors, and scales [1].
The choice depends on the customer setting. A manufacturer with existing PLM-controlled engineering data may evaluate Sequence's stated PLM connectivity more closely. A manufacturer seeking to connect scales, sensors, and cameras directly into operator workflows may evaluate Tulip's edge connectivity claims. Neither source provides comparative performance data, pricing, or validation evidence. The sources also do not state which medical device manufacturers use either platform beyond Tulip's reference to a custom prosthetic manufacturer case study [1]. The case study title states that the manufacturer decreased custom medical device assembly by 60% with Tulip, but the source does not provide the underlying data or validation evidence [1]. A procurement decision requires vendor-specific validation documentation, not marketing descriptions.
A Concrete Evaluation Example
Consider a hypothetical manufacturer assembling a Class II electromechanical surgical instrument. The quality team wants digital work instructions that require an operator to scan a lot number, confirm a torque measurement from a connected tool, and apply an electronic signature before the next step unlocks. The team would first document whether the platform is a device software function or manufacturing support software. The device software functions guidance states that it does not apply to automated manufacturing and Quality System software or software that is not a device [5]. If the platform is OTS software, the team would prepare the description and risk assessment elements described in the OTS guidance, including the title and manufacturer, version level, release date, patch number, and upgrade designation as appropriate, and the expected design limitations [6].
The team would then evaluate Tulip and Sequence against three documented requirements. First, can the platform enforce the torque measurement as a mandatory step with a connected tool? Tulip describes edge connectivity for connected tools, sensors, and scales [1]. Sequence lists mandatory in-process quality checks and measurement capture among its medical device manufacturing capabilities [2]. Second, can the platform generate an eDHR with the correct revision for each lot? Both vendors describe this capability [1][2]. Third, can the platform support 21 CFR Part 11 electronic signatures with an audit trail? Both vendors state this support [1][2]. The evaluation would require a documented test of each requirement in the manufacturer's own environment, not reliance on vendor claims.
Sources & references
- Digital Work Instructions for Medical Device Manufacturers | Tulip · tulip.co
- Medical Device Manufacturing Work Instructions | Sequence Software · www.sequencesoftware.com
- Content of Premarket Submissions for Device Software Functions · www.fda.gov
- Applying Human Factors and Usability Engineering to Medical Devices · www.fda.gov
- Content of Premarket Submissions for Device Software Functions — Guidance for Industry and FDA Staff (June 14, 2023) · www.fda.gov
- Off-the-Shelf Software Use in Medical Devices · www.fda.gov
- Medical Device Software Guidance Navigator | FDA · www.fda.gov
- Digital Work Instructions for Error Proofing · www.picomes.com